Pola Kepribadian dan Sindroma Klinis Pasien Rehabilitasi Napza di RSJ Provinsi Bali
Article Sidebar
Read Counter : 14
Download : 11
Main Article Content
Putu Asih Primatanti
Gde Yudhi Kurniawan
Abstract
Prevalensi pengguna Napza di Indonesia selama tahun 2021 mengalami peningkatan sebesar 0,15%, sehingga menjadi 1,95% atau 3,66 juta jiwa. Beberapa program dilakukan untuk mengurangi prevalensi tersebut, termasuk program rehabilitasi yang dilakukan di RSJ Provinsi Bali. Salah satunya adalah dengan melakukan identifikasi pola kepribadian dan sindroma klinis memakai Millon Clinical Multiaxial Inventory. Tujuan penelitian adalah untuk mengidentifikasi pola kepribadian dan sindroma klinis berdasarkan identifikasi Millon Clinical Multiaxial Inventory pada pasien rehabilitasi Napza di RSJ Provinsi Bali selama tahun 2021-2022. Penelitian ini menggunakan rancangan penelitian analitik potong lintand. Data diambil dari rekam medis selama dua tahun yang meliputi karakteristik pasien, pola kepribadian dan sindroma klinis dari MCMI-IV. Sampel diambil menggunakan metode total sampling yang memenuhi kriteria inklusi dan eksklusi. Dari hasil penelitian dilakukan analisis 76 data responden tahun 2021-2022, dengan karakteristik responden seluruhnya berjenis kelamin laki-laki, terbanyak pada kelompok usia 25-29 tahun, pendidikan terakhir adalah SMA/sederajat, bekerja sebagai karyawan swasta, berasal dari kabupaten Buleleng, dan menggunakan Napza jenis stimulan. Clinical personality pattern terbanyak adalah narsisistik (94,7%), severe personality pathology terbanyak adalah paranoid (88,2%), dan clinical syndrome terbanyak selain penggunaan Napza (96,1%) adalah spektrum bipolar (88,2%). Terdapat hubungan yang signifikan antara clinical personality pattern dengan clinical syndrome (p<0,05).
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Badan Narkotika Nasional (BNN). Puslitdatin BNN. Data Statistik Kasus Napza. Available from: https://puslitdatin.bnn.go.id/portfolio/data-statistik-kasus-narkoba/
Pelegrino J. Drug Rehabilitation Program from the Lens of Surrenderees. Int J Sci Basic Appl Res. 2022 Apr 9;62:235–49.
Nurhotimah N, Besral B. Factors Affecting Non-Compliance with Drug Abuse Rehabilitation Program at The Clinic of The National Narcotics Board. In: 6th International Conference on Public Health 2019. Sebelas Maret University.; 2019. p. 137–45.
Sellbom M, Flens J, Gould J, Ramnath R, Tringone R, Grossman S. The Millon Clinical Multiaxial Inventory-IV (MCMI-IV) and Millon Adolescent Clinical Inventory-II (MACI-II) in Legal Settings. J Pers Assess. 2022;104(2):203–20.
Choca J., Pignolo C. Assessing Negative Response Bias with the Millon Clinical Multiaxial Inventory-IV (MCMI-IV): a Review of the Literature. Psychol Inj Law. 2022;15(3):1–8.
Mohammadi MR, Hooshyari Z, Delavar A, Amanat M, Mohammadi A, Abasi I, et al. Diagnostic validity of millon clinical multiaxial inventory-IV (MCMI-IV). Curr Psychol. 2022;1–9.
Hindradjat J, Ramli M, Radjah C. Case Study On The Use of Cognitive Behavior Therapy (CBT) in Reducing Depression Levels in Adult Women. J Ilmu Keperawatan Jiwa. 4(2):263–72.
Bucher M, Suzuki T, Samuel D. A meta-analytic review of personality traits and their associations with mental health treatment outcomes. Clin Psychol Rev. 2019 Apr 1;70:51–63.
Andersson H, Steinsbekk A, Walderhaug E, Otterholt E, Nordfjærn T. Predictors of Dropout From Inpatient Substance Use Treatment: A Prospective Cohort Study. Subst Abus Res Treat. 2018 Jan 31;12:1–10.
Lappan S., Brown A., Hendricks P. Dropout rates of in‐person psychosocial substance use disorder treatments: a systematic review and meta‐analysis. Addiction. 2020;115(2):201–17.
Raharni R, Idaiani S, Prihatini N. Kekambuhan pada Pasien Penyalahguna Narkotika, Psikotropika, Zat Adiktif (Napza) Pasca Rehabilitasi: Kebijakan dan Program Penanggulangan. Media Penelit dan Pengemb Kesehat. 2020;30(2):183–98.
Badan Narkotika Nasional (BNN). PPID BNN. 2017. Survey Nasional Penyalahgunaan Narkoba di 34 Provinsi Tahun 2017.
Zilberman N, Yadid G, Efrati Y, Neumark Y, Rassovsky Y. Personality profiles of substance and behavioral addictions. Addict Behav. 2018;82:174–81.
Yamada C, Siste K, Hanafi E, Ophinni Y, Beatrice E, Rafelia V, et al. Relapse prevention group therapy via video-conferencing for substance use disorder: protocol for a multicentre randomised controlled trial in Indonesia. BMJ Open. 2021 Sep 1;11(9):e050259.
Depkes RI. Pedoman Penggolongan dan Diagnosis Gangguan Jiwa III (PPDGJ-III). Direktorat Kesehatan Jiwa Depkes RI; 2000.
Parmar A, Kaloiya G. Comorbidity of personality disorder among substance use disorder patients: A narrative review. Indian J Psychol Med. 2018;40(6):517–27.
Price LA. Millon Clinical Multiaxial Inventory-IV (MCMI-IV) Profile Patterns and Scale Score Correlates for Jail Inmates Referred for Mental Health Services. Florida Tech. 2019;
Qassimi F, Boujraf S, Khlifi A, Lamgari G, El Bourachedy Z, Aarab C, et al. Substance Use Disorder, Alexithymia, and Personality Disorders, What is the Link? Pilot African Study. OBM Neurobiol [Internet]. 2023;07(03):176. Available from: https://doi.org/10.21926/obm.neurobiol.2303176
Hanegraaf L, Arunogiri S, Hohwy J, Verdejo-Garcia A. Dysfunctional personality beliefs and emotion recognition in individuals with methamphetamine dependence. Addict Behav. 2020 Jun;105:106336.
Dom G, Moggi F. Co-occurring Addictive and Psychiatric Disorders. Number1 ed. Dom G, Moggi F, editors. Berlin, Heidelberg: PublisherSpringer; 2016. 389 p.
Verheul R. Co-morbidity of personality disorders in individuals with substance use disorders. Eur Psychiatry. 2001 Aug;16(5):274–82.
Verheul R, van den Brink W. The role of personality pathology in the aetiology and treatment of substance use disorders. Curr Opin Psychiatry [Internet]. 2000;13(2):163–9. Available from: https://journals.lww.com/co-psychiatry/fulltext/2000/03000/the_role_of_personality_pathology_in_the_aetiology.5.aspx
Alegría AA, Hasin DS, Nunes E V, Liu SM, Davies C, Grant BF, et al. Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2010 Sep;71(9):1183–7.
Soraya S, Mahdavi M, Saeidi M, Seddigh R, Nooraeen S, Sadri M, et al. Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study. Middle East Curr Psychiatry [Internet]. 2022;29(1):30. Available from: https://doi.org/10.1186/s43045-022-00197-x
Hunt GE, Malhi GS, Cleary M, Lai HMX, Sitharthan T. Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis. J Affect Disord. 2016 Dec;206:321–30.
Preuss UW, Schaefer M, Born C, Grunze H. Bipolar Disorder and Comorbid Use of Illicit Substances. Medicina (Kaunas). 2021 Nov;57(11).
Mellos E, Liappas I, Paparrigopoulos T. Comorbidity of personality disorders with alcohol abuse. In Vivo. 2010;24(5):761–9.
Tiffon B. Crime against a minor and dissociative phenomenon due to the combined effect of toxic consumption by the offender. South Florida J Heal. 2022;3(1):13–20.